Freya Biosciences ApS: Financial statements 2024
CVR: 41257547
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Freya Biosciences ApS (CVR 41257547) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -6,657,479 and a net result of DKK -85,434,294 compared with DKK -81,096,000 the year before. Equity in the 2024 report amounted to DKK 130,067,351. The solvency ratio was 92%. The company had 14 employees in the financial year.
- Gross Profit
- DKK -6,657,479
- Profit/Loss
- DKK -85,434,294
- Equity
- DKK 130,067,351
- Total Assets
- DKK 141,431,174
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -6.7 mio. | -85.4 mio. | 130.1 mio. | 14 |
| 2023 | - | -5.4 mio. | -81.1 mio. | 75 mio. | 14 |
| 2022 | - | -16.6 mio. | -32.2 mio. | -3.7 mio. | - |
| 2021 | 0 | -5.5 mio. | -20.4 mio. | 28.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 30, 2024, David Lawrence Stern has joined the board of directors of Freya Biosciences ApS.
As of September 30, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
As of September 30, 2024, is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
As of September 30, 2024, is registered as an owner of Freya Biosciences ApS with an ownership share of 10%.
Freya Biosciences ApS has published its annual report for 2023. Gross profit came to DKK -5,366,000, and the net result was DKK -81,096,000.
About Freya Biosciences ApS
Freya Biosciences ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include Danmarks Eksport- og Investeringsfond, OMX Ventures Fund I, LLC and Sofinnova Capital IX. The company has 18 employees (2026). In 2025, the company reported a gross profit of DKK -14,130,000 and a net result of DKK -92,714,000 compared with DKK -85,434,294 the year before. Equity in the 2025 report amounted to DKK 72,025,000.